Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 10 ZURA Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
May 10 EHAB Enhabit Inc (EHAB) Reports Mixed Q1 2024 Results: Challenges and Strategic Adjustments Highlighted
May 10 EMBC Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024
May 10 EMBC Embecta Second Quarter 2024 Earnings: Beats Expectations
May 9 EMBC Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
May 9 ZURA Zura Bio reports Q1 results
May 9 EHAB AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
May 9 EHAB Enhabit challenged by hedge fund AREX Capital seeking seven board seats - report
May 9 EMBC Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
May 9 ZURA Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 8 EHAB Enhabit (EHAB) Beats Q1 Earnings Estimates
May 8 EHAB Enhabit GAAP EPS of $0.01, revenue of $262.4M
May 8 EHAB Enhabit concludes review of strategic alternatives
May 8 EHAB Enhabit Concludes Review of Strategic Alternatives
May 8 EHAB Enhabit Reports First Quarter 2024 Financial Results
May 8 AMED Amedisys gains amid report of sweetened divestiture offer in UnitedHealth deal
May 8 TNDM Tandem insulin pump error leads to FDA Class I recall
May 7 EHAB Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
May 5 TNDM Earnings Update: Here's Why Analysts Just Lifted Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$43.57
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags